Amid market volatility, technical analysis can help investors pinpoint promising stock opportunities. Using TipRanks’ Technical Analysis Screener, ......

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Genmab (GMAB – Research Report), Omnicell (OMCL – Re......

In a report released today, Xian Deng from UBS maintained a Buy rating on Genmab A/S, with a price target of DKK2,700.00. Deng covers the Healthcar......

In a report released on November 25, Sachin Jain from Bank of America Securities maintained a Buy rating on Genmab A/S, with a price target of DKK2......

Genmab ( ($GMAB) ) has provided an update. On November 20, 2025, Genmab A/S announced the grant of 6,933 restricted stock units and 7,377 warrants ......

Genmab ( ($GMAB) ) just unveiled an update. On November 19, 2025, Genmab A/S announced transactions involving shares and linked securities conducte......

Genmab ( ($GMAB) ) has provided an announcement. Genmab A/S has updated its Articles of Association, authorizing the Board of Directors to increase......

The latest announcement is out from Genmab ( ($GMAB) ). On November 18, 2025, Genmab A/S announced a capital increase of 32,059 shares following th......

Genmab ( ($GMAB) ) just unveiled an update. On November 18, 2025, Genmab A/S announced that the U.S. FDA approved EPKINLY® (epcoritamab-bysp) in co......

In a report released on November 14, Jon Berggren from Kepler Capital maintained a Hold rating on Genmab A/S, with a price target of DKK2,100.00. T......